ImmuCell Corporation
Statements
Ratios
Valuation ratios (P/E, P/S, EV/EBITDA and the other multiples) are based on the closing price at the end of each period, not on the current price. Margins and returns are shown in percent, multiples without a unit, per-share figures in the reporting currency, net debt in millions.
Tick rows to compare them in a chart (up to 4)
| Line item | 1996 | 1997 | 1998 | 1999 | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Valuation | ||||||||||||||||||||||||||||||
| – | 25.0 | – | 11.0 | 2.0 | 24.7 | 5.3 | 26.8 | 148.8 | 22.5 | 28.3 | 16.5 | – | – | – | – | 138.9 | 113.0 | – | 19.6 | 51.2 | – | – | – | – | – | – | – | – | – | |
| 1.5 | 1.6 | 0.7 | 1.2 | 0.8 | 1.6 | 0.8 | 3.3 | 5.8 | 3.2 | 3.8 | 1.8 | 1.1 | 2.4 | 2.2 | 2.7 | 2.3 | 2.2 | 2.0 | 2.3 | 2.7 | 4.2 | 3.5 | 2.6 | 2.8 | 3.2 | 2.5 | 2.3 | 1.6 | 2.0 | |
| 3.4 | 3.3 | 1.4 | 2.1 | 0.8 | 1.7 | 0.7 | 1.5 | 2.8 | 1.9 | 2.0 | 1.1 | 0.5 | 1.1 | 1.0 | 1.6 | 1.4 | 1.4 | 1.6 | 2.2 | 1.3 | 1.8 | 1.8 | 1.2 | 1.5 | 1.9 | 1.6 | 1.6 | 1.5 | 2.1 | |
| 1.3 | 1.5 | – | 0.9 | 0.5 | 1.3 | – | 121.4 | – | – | 3.6 | – | 0.8 | – | 2.1 | 2.9 | 2.1 | 2.0 | 2.0 | 2.5 | 2.5 | 4.7 | 4.2 | 2.7 | 2.9 | 3.1 | 2.8 | 2.9 | 1.9 | 2.2 | |
| 57.5 | 16.8 | – | 5.9 | 5.6 | 10.5 | – | – | – | – | 16.4 | – | – | – | – | – | 16.5 | 17.5 | 59.4 | 9.6 | 13.9 | 73.6 | 516.1 | 28.6 | 46.5 | 22.2 | 274.2 | – | 46.6 | 28.7 | |
| – | – | 6.3 | 11.0 | – | 1,037.1 | 2.9 | 10.0 | 20.9 | 27.5 | 334.1 | – | – | – | – | – | 180.2 | 26.5 | – | 131.1 | – | – | – | – | – | – | – | – | – | 45.7 | |
| -7.6% | – | 15.9% | 9.1% | -4.3% | 0.1% | 35.0% | 10.0% | 4.8% | 3.6% | 0.3% | -10.8% | -7.3% | -5.2% | -9.7% | -2.0% | 0.6% | 3.8% | -8.3% | 0.8% | -15.0% | -38.1% | -6.3% | -3.3% | -6.4% | -2.7% | -11.7% | -16.6% | -0.3% | 2.2% | |
| Margins | ||||||||||||||||||||||||||||||
| 59.1% | 63.0% | 57.8% | 58.2% | 52.7% | 51.8% | 54.7% | 59.9% | 60.8% | 67.2% | 60.8% | 62.6% | 44.8% | 53.3% | 52.5% | 55.1% | 56.7% | 50.9% | 58.6% | 61.1% | 56.8% | 50.1% | 47.3% | 49.1% | 44.7% | 45.0% | 41.2% | 25.2% | 30.0% | 41.4% | |
| -2.3% | 6.5% | – | 12.5% | 7.3% | 10.0% | 8.6% | -12.8% | 3.3% | 18.8% | 16.1% | 14.4% | -25.2% | -11.7% | -15.7% | -12.4% | 4.5% | -0.3% | -2.7% | 20.7% | 9.3% | -2.3% | -13.2% | -7.0% | -9.0% | 1.3% | -12.4% | -32.9% | -6.2% | 6.0% | |
| -2.3% | 6.5% | -2.2% | 11.2% | 39.4% | 6.3% | 14.3% | 12.2% | 3.9% | 14.2% | 13.5% | 10.9% | -10.1% | -4.8% | -8.8% | -8.0% | 1.7% | 2.0% | -2.2% | 11.9% | 5.3% | -1.6% | -21.1% | -9.4% | -6.7% | -0.4% | -13.4% | -33.1% | -8.1% | -3.8% | |
| -11.4% | – | 11.1% | 11.2% | -3.4% | 0.1% | 26.7% | 32.8% | 27.6% | 11.6% | 1.1% | -19.4% | -7.7% | -12.6% | -21.1% | -5.5% | 1.3% | 8.3% | -16.2% | 1.8% | -41.0% | -159.0% | -21.9% | -8.4% | -18.0% | -8.6% | -29.7% | -37.6% | -0.4% | 4.4% | |
| Returns | ||||||||||||||||||||||||||||||
| -5.3% | 13.0% | -4.5% | 19.6% | 40.1% | 6.9% | 12.7% | 5.6% | 1.9% | 8.3% | 6.9% | 6.6% | -4.9% | -2.2% | -4.1% | -4.5% | 1.0% | 1.2% | -1.8% | 11.4% | 2.6% | -0.7% | -10.7% | -4.5% | -3.6% | -0.2% | -8.2% | -23.1% | -7.8% | -3.8% | |
| -3.2% | 9.4% | -3.2% | 14.3% | 34.5% | 5.9% | 11.8% | 5.0% | 1.5% | 7.1% | 5.7% | 6.4% | -4.6% | -2.2% | -3.6% | -3.7% | 0.8% | 1.1% | -1.5% | 8.3% | 2.1% | -0.5% | -7.1% | -3.3% | -2.5% | -0.2% | -5.6% | -13.2% | -4.8% | -2.4% | |
| Balance Sheet & Debt | ||||||||||||||||||||||||||||||
| -0.8 | -0.8 | – | -1.8 | -1.5 | -1.5 | – | 397 | – | – | -1.1 | – | -1.2 | – | -0.4 | 0.7 | -1.3 | -1.2 | 0.1 | 1.7 | -2.1 | 5.2 | 7.2 | 2.1 | 1.7 | -0.9 | 4.5 | 12 | 7.2 | 5.4 | |
| -8.0 | -2.0 | – | -2.5 | -2.7 | -1.7 | – | – | – | – | -1.0 | – | – | – | – | – | -2.0 | -1.7 | 0.3 | 0.7 | -1.2 | 7.8 | 81.9 | 1.6 | 1.7 | -0.3 | 23.7 | – | 6.8 | 2.5 | |
| 61.3% | 71.9% | 71.0% | 73.0% | 86.0% | 85.0% | 92.6% | 90.0% | 81.1% | 86.0% | 82.1% | 96.6% | 95.2% | 96.4% | 86.3% | 82.1% | 83.4% | 85.7% | 83.8% | 72.7% | 79.9% | 68.8% | 66.4% | 74.9% | 70.1% | 73.3% | 67.7% | 57.1% | 61.0% | 63.6% | |
| 0.1 | 0.1 | – | 0.0 | 0.1 | 0.1 | – | 54.3 | – | – | 0.0 | – | 0.0 | – | 0.1 | 0.2 | 0.1 | 0.1 | 0.1 | 0.3 | 0.2 | 0.4 | 0.4 | 0.3 | 0.3 | 0.3 | 0.3 | 0.5 | 0.4 | 0.3 | |
| Per Share | ||||||||||||||||||||||||||||||
| -0.04 | 0.10 | -0.04 | 0.22 | 0.79 | 0.15 | 0.32 | 0.15 | 0.05 | 0.24 | 0.21 | 0.22 | -0.16 | -0.07 | -0.13 | -0.14 | 0.03 | 0.04 | -0.06 | 0.38 | 0.12 | -0.03 | -0.42 | -0.19 | -0.14 | -0.01 | -0.32 | -0.75 | -0.26 | -0.12 | |
| 1.61 | 1.53 | 1.85 | 1.95 | 2.00 | 2.38 | 2.23 | 1.19 | 1.25 | 1.66 | 1.57 | 2.00 | 1.60 | 1.52 | 1.48 | 1.71 | 1.73 | 1.95 | 2.51 | 3.23 | 2.20 | 2.11 | 2.00 | 2.01 | 2.13 | 2.53 | 2.40 | 2.26 | 3.24 | 3.06 | |
| 0.70 | 0.77 | 0.91 | 1.12 | 1.96 | 2.16 | 2.51 | 2.61 | 2.61 | 2.85 | 3.06 | 3.31 | 3.33 | 3.25 | 3.12 | 3.02 | 2.96 | 3.05 | 3.06 | 3.35 | 4.55 | 4.77 | 3.96 | 4.25 | 3.92 | 4.29 | 3.92 | 3.23 | 3.37 | 3.00 | |
| -0.18 | – | 0.21 | 0.22 | -0.07 | 0.00 | 0.60 | 0.39 | 0.34 | 0.19 | 0.02 | -0.39 | -0.12 | -0.19 | -0.31 | -0.09 | 0.02 | 0.16 | -0.41 | 0.06 | -0.90 | -3.35 | -0.44 | -0.17 | -0.38 | -0.22 | -0.71 | -0.85 | -0.01 | 0.14 | |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.